Broad-Spectrum Antiviral Activity of the Deubiquitinase Inhibitor HBX against Human Adenoviruses

Wold WSH, Adenoviruses. In Fields B.N. , Knipe D.M. , Howley P.M. (Editors). Virology. Vol. 2. Philadelphia, PA: Lippincott-Raven 2007; p. 2395–2436.

Berk A.J. Adenoviridae: the viruses and their replication. In Fields B.N. , Knipe D.M. , Howley P.M. (Editors). Virology. Vol. 2. Philadelphia, PA: Lippincott-Raven 2007; p. 2355–2394.

Wy Ip W. , Qasim W. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol 2013; 2013: 176418.

Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 2014; 27: 441–462.

Mynarek M. , Ganzenmueller T. , Mueller-Heine A. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program. Biol Blood Marrow Transplant 2014; 20: 250–256.

Schilham M.W. , Claas E.C. , van Zaane W. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35: 526–532.

Lion T. , Kosulin K. , Landlinger C. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010; 24: 706–714.

Schilham M.W. , Claas E.C. , van Zaane W. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis 2002; 35: 526–532.

Campbell S.J. , Kynyk J.A. , Davis J.A. Disseminated adenovirus infection causing severe ARDS. BMJ Case Rep 2017; doi:10.1136/bcr-2016-217524.

Lam E. , Ramke M. , Warnecke G. Effective apical infection of differentiated human bronchial epithelial cells and induction of proinflammatory chemokines by the highly pneumotropic human adenovirus type 14p1. PLoS One 2015; 10: e0131201.

Hung K.H. , Lin L.H. Adenovirus pneumonia complicated with acute respiratory distress syndrome: a case report. Medicine (Baltimore) 2015; 94: e776.

Klinger J.R. , Sanchez M.P. , Curtin L.A. , Durkin M. , Matyas B. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med 1998; 157: 645–649.

Ishiko H. , Shimada Y. , Konno T. Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis. J Clin Microbiol 2008; 46: 2002–2008.

Henquell C. , Boeuf B. , Mirand A. Fatal adenovirus infection in a neonate and transmission to health-care workers. J Clin Virol 2009; 45: 345–348.

Gopalkrishna V. , Ganorkar N.N. , Patil P.R. Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India. J Med Virol 2016; 88: 2100–2105.

Hage E. , Espelage W. , Eckmanns T. Molecular phylogeny of a novel human adenovirus type 8 strain causing a prolonged, multi-state keratoconjunctivitis epidemic in Germany. Sci Rep 2017; 7: 40680.

Morfin F. , Dupuis-Girod S. , Frobert E. In vitro susceptibility of adenovirus to antiviral drugs is species dependent. Antivir Ther 2005; 10: 225–229.

Matthes-Martin S. , Feuchtinger T. , Shaw P.J. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14: 555–563.

Lindemans C.A. , Leen A.M. , Boelens J.J. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010; 116: 5476–5485.

Yusuf U. , Hale G.A. , Carr J. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81: 1398–1404.

Bhadri V.A. , Lee-Horn L. , Shaw P.J. Safety and tolerability of cidofovir in high-risk pediatric patients. Transpl Infect Dis 2009; 11: 373–379.

George D. , El-Mallawany N.K. , Jin Z. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol 2012; 156: 99–108.

Toth K. , Spencer J.F. , Dhar D. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc Natl Acad Sci U S A 2008; 105: 7293–7297.

Florescu D.F. , Pergam S.A. , Neely M.N. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant 2012; 18: 731–738.

Grimley M.S. , Chemaly R.F. , Englund J.A. Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled Phase II trial. Biol Blood Marrow Transplant 2017; 23: 512–521.

Andersson E.K. , Strand M. , Edlund K. Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino) benzoyl]amino}-benzoic acid as a novel antiadenoviral compound. Antimicrob Agents Chemother 2010; 54: 3871–3877.

Sanchez-Cespedes J. , Moyer C.L. , Whitby L.R. , Boger D.L. , Nemerow G.R. Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative. Antiviral Res 2014; 108: 65–73.

Geyeregger R. , Freimuller C. , Stemberger J. First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation. J Immunother 2014; 37: 245–249.

Leen A.M. , Bollard C.M. , Mendizabal A.M. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 2013; 121: 5113–5123.

Feuchtinger T. , Matthes-Martin S. , Richard C. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134: 64–76.

Harrigan J.A. , Jacq X. , Martin N.M. , Jackson S.P. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 2018; 17: 57–78.

Jäger W. , Santag S. , Weidner-Glunde M. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA. J Virol 2012; 86: 6745–6757.

Meredith M. , Orr A. , Everett R. Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology 1994; 200: 457–469.

Saridakis V. , Sheng Y. , Sarkari F. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 2005; 18: 25–36.

Sivachandran N. , Sarkari F. , Frappier L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 2008; 4: e1000170.

Ching W. , Koyuncu E. , Singh S. A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation. PLoS Pathog 2013; 9: e1003273.

Ching W. , Dobner T. , Koyuncu E. The human adenovirus type 5 E1B 55-kilodalton protein is phosphorylated by protein kinase CK2. J Virol 2012; 86: 2400–2415.

Hierholzer J.C. , Killington R.A. Virus isolation and quantification. In Mahy B.W.J. , and Kangro H.O. (Editors). Virology Methods Manual. Cambridge: Academy Press 1996; p. 25–46.

Markel D. , Lam E. , Harste G. , Darr S. , Ramke M. , Heim A. Type dependent patterns of human adenovirus persistence in human T-lymphocyte cell lines. J Med Virol 2014; 86: 785–794.

Popp F. Synthesis of potential antineoplastic agents. XXI. Compounds related to ellipticine (1). J Heterocycl Chem 1972; 9: 1399–1401.

Blackford A.N. , Bruton R.K. , Dirlik O. A role for E1B-AP5 in ATR signaling pathways during adenovirus infection. J Virol 2008; 82: 7640–7652.

Forrester N.A. , Sedgwick G.G. , Thomas A. Serotype-specific inactivation of the cellular DNA damage response during adenovirus infection. J Virol 2011; 85: 2201–2211.

Heim A. , Ebnet C. , Harste G. , Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by realtime PCR. J Med Virol 2003; 70: 228–239.

Dix B.R. , O'Carroll S.J. , Myers C.J. , Edwards S.J. , Braithwaite A.W. Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53. Cancer Res 2000; 60: 2666–2672.

Querido E. , Blanchette P. , Yan Q. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 2001; 15: 3104–3117.

Cummins J.M. , Vogelstein B. HAUSP is required for p53 destabilization. Cell Cycle 2004; 3: 687–690.

Sheng Y. , Saridakis V. , Sarkari F. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol 2006; 13: 285–291.

Colland F. , Formstecher E. , Jacq X. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther 2009; 8: 2286–2295.

Ma J. , Martin J.D. , Xue Y. C-terminal region of USP7/ HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Arch Biochem Biophys 2010; 503: 207–212.